NCT04021108 2025-06-24Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)Weill Medical College of Cornell UniversityPhase 2 Active not recruiting80 enrolled